Senner Christopher J., EVP and CFO of Exelixis, Inc. ($EXEL), sold about 7.4 million dollars worth of shares in three open market transactions over the last year. His most recent sale occurred on February 17, 2026. These sales rank 1430th among 11,678 individual insiders, below the average of 8.6 million dollars per seller and 6.37 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 52018 | $0.00 | 1,030,833.0000 | 281,863,000 | 5.31% | 0.02% |
| Feb. 15, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 35870 | $43.92 | 1,009,432.0000 | 281,863,000 | 3.43% | 0.01% |
| Feb. 17, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 30617 | $43.67 | 978,815.0000 | 281,863,000 | 3.03% | 0.01% |
| Feb. 13, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 34278 | $43.00 | 1,045,302.0000 | 281,863,000 | 3.18% | 0.01% |
| Jan. 2, 2026 | Quince Therapeutics, Inc. | $QNCX | Senner Christopher J. | Not found | A | Director Stock Option (Right to Buy) | 21810 | $0.00 | 21,810.0000 | 55,681,490 | 9999.99% | 0.04% |
| Jan. 15, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 40459 | $45.23 | 1,079,580.0000 | 281,863,000 | 3.61% | 0.01% |
| Jan. 15, 2026 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 149474 | $0.00 | 1,120,039.0000 | 281,863,000 | 15.40% | 0.05% |
| June 4, 2025 | Quince Therapeutics, Inc. | $QNCX | Senner Christopher J. | Not found | A | Director Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 44,001,643 | 9999.99% | 0.06% |
| May 16, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Common Stock | 100000 | $18.80 | 1,070,565.0000 | 296,132,000 | 10.30% | 0.03% |
| May 16, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Option (right to buy) | 100000 | $0.00 | 0.0000 | 296,132,000 | 100.00% | 0.03% |
| May 15, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 41422 | $44.65 | 970,565.0000 | 296,132,000 | 4.09% | 0.01% |
| May 16, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 100000 | $46.00 | 970,565.0000 | 296,132,000 | 9.34% | 0.03% |
| March 31, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 170009 | $0.00 | 1,011,987.0000 | 296,132,000 | 20.19% | 0.06% |
| Feb. 26, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 59648 | $0.00 | 841,978.0000 | 296,132,000 | 7.62% | 0.02% |
| Feb. 24, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 29314 | $36.14 | 782,330.0000 | 296,132,000 | 3.61% | 0.01% |
| Feb. 24, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Common Stock | 29314 | $18.80 | 811,644.0000 | 296,132,000 | 3.75% | 0.01% |
| Feb. 24, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Option (right to buy) | 29314 | $0.00 | 100,000.0000 | 296,132,000 | 22.67% | 0.01% |
| Feb. 15, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 21591 | $35.00 | 782,330.0000 | 296,132,000 | 2.69% | 0.01% |
| Jan. 16, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 132973 | $0.00 | 839,870.0000 | 296,132,000 | 18.81% | 0.04% |
| Jan. 16, 2025 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 35949 | $37.27 | 803,921.0000 | 296,132,000 | 4.28% | 0.01% |
| Jan. 2, 2025 | Quince Therapeutics, Inc. | $QNCX | Senner Christopher J. | Not found | A | Director Stock Option (right to buy) | 35274 | $0.00 | 35,274.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 17506 | $35.05 | 706,897.0000 | 296,994,000 | 2.42% | 0.01% |
| Aug. 9, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Option (right to buy) | 125000 | $0.00 | 0.0000 | 321,464,000 | 100.00% | 0.04% |
| Aug. 9, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Common Stock | 125000 | $24.41 | 849,403.0000 | 321,464,000 | 17.26% | 0.04% |
| Aug. 9, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 125000 | $27.19 | 724,403.0000 | 321,464,000 | 14.72% | 0.04% |
| June 5, 2024 | Quince Therapeutics, Inc. | $QNCX | Senner Christopher J. | Not found | A | Employee Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 11478 | $20.99 | 724,403.0000 | 321,464,000 | 1.56% | 0.00% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 10211 | $20.99 | 735,881.0000 | 321,464,000 | 1.37% | 0.00% |
| May 15, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 8621 | $20.99 | 746,092.0000 | 321,464,000 | 1.14% | 0.00% |
| Feb. 23, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 82121 | $0.00 | 754,713.0000 | 321,464,000 | 12.21% | 0.03% |
| Jan. 11, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 21862 | $22.86 | 672,592.0000 | 321,464,000 | 3.15% | 0.01% |
| Jan. 11, 2024 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 80186 | $0.00 | 694,454.0000 | 321,464,000 | 13.05% | 0.02% |
| Sept. 6, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 65135 | $0.00 | 631,415.0000 | 324,556,000 | 11.50% | 0.02% |
| Sept. 6, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 17147 | $22.27 | 614,268.0000 | 324,556,000 | 2.72% | 0.01% |
| Aug. 15, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 8074 | $21.51 | 566,280.0000 | 324,556,000 | 1.41% | 0.00% |
| Aug. 3, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 60000 | $20.51 | 574,354.0000 | 324,556,000 | 9.46% | 0.02% |
| Aug. 4, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Common Stock | 60000 | $14.74 | 634,354.0000 | 324,556,000 | 10.45% | 0.02% |
| Aug. 4, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | S | Common Stock | 60000 | $20.68 | 574,354.0000 | 324,556,000 | 9.46% | 0.02% |
| Aug. 3, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 324,556,000 | 50.00% | 0.02% |
| Aug. 4, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Option (right to buy) | 60000 | $0.00 | 0.0000 | 324,556,000 | 100.00% | 0.02% |
| Aug. 3, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | M | Common Stock | 60000 | $14.74 | 634,354.0000 | 324,556,000 | 10.45% | 0.02% |
| May 15, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 10002 | $19.18 | 574,354.0000 | 324,556,000 | 1.71% | 0.00% |
| May 15, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 8444 | $19.18 | 584,356.0000 | 324,556,000 | 1.42% | 0.00% |
| April 3, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | A | Common Stock | 85414 | $0.00 | 592,800.0000 | 324,556,000 | 16.83% | 0.03% |
| Feb. 15, 2023 | EXELIXIS, INC. | $EXEL | Senner Christopher J. | EVP and CFO | F | Common Stock | 5278 | $18.08 | 507,386.0000 | 324,556,000 | 1.03% | 0.00% |